237 results match your criteria: "Institute of Human Virology - Nigeria[Affiliation]"

Advancing the prevention and treatment of HIV in children: priorities for research and development.

Lancet HIV

September 2022

ICAP, Columbia University, New York, NY, USA; Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Article Synopsis
  • The WHO Paediatric Drug Optimization for HIV (PADO-HIV) group aims to enhance HIV treatment and prevention for children by identifying and prioritizing safe and effective drug formulations every 2-3 years.
  • PADO-HIV 5, which met from Sept 27 to Oct 15, 2021, assessed various HIV treatment options, including new drug classes and delivery methods, focusing specifically on the needs of neonates and innovative technologies.
  • The group produced a list of research priorities and questions to guide funders and developers, aiming to improve access to the best HIV medications for children in low- and middle-income countries.
View Article and Find Full Text PDF

How Do Psychosocial Interventions for Adolescents and Young People Living With HIV Improve Adherence and Viral Load? A Realist Review.

J Adolesc Health

September 2022

Institute for Life Course Health Research, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa.

Purpose: Psychosocial interventions have the potential to support adolescents and young people living with HIV (AYPLHIV) to achieve better HIV outcomes. However, more evidence is needed to understand which interventions are most effective, and the mechanisms driving how they work in practice.

Methods: We used realist methodologies to generate statements based on evidence from intervention studies and linked evidence included in a systematic review of psychosocial interventions for AYPLHIV.

View Article and Find Full Text PDF

Health Equity in Pediatric Drug Development: Translating Aspiration into Operation.

Ther Innov Regul Sci

November 2022

Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool Health Partners, Liverpool, UK.

The concept of health equity-the attainment of the highest possible level of health for all members of society-requires equitable access to all aspects of healthcare, including pediatric drug development. However, many communities are under-represented in pediatric drug development programs. Barriers to participation include geographic, economic, racial/ethnic bias, legal, cultural, linguistic, and other factors.

View Article and Find Full Text PDF

The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study.

Arch Public Health

May 2022

Department of Public Health, Institute for Global Health and Epidemiology, Faculty of Health Sciences and Social Work, Trnava University, Trnava, Slovakia.

Article Synopsis
  • Injury is a significant public health concern in Europe, with notable differences in injury death rates and disability-adjusted life years (DALYs) across sub-regions and countries, particularly between Eastern, Central, and Western Europe.
  • The study analyzed GBD 2019 data from 44 European countries over 20 years, focusing on injury mortality and DALY rates by cause and sex while assessing inequalities based on country comparisons.
  • Findings reveal that Eastern Europe has the highest injury death rates (80 deaths per 100,000), while Italy has the lowest injury DALY rate, indicating that males experience greater disparities in injury impact than females.
View Article and Find Full Text PDF

The African Female Breast Cancer Epidemiology Study Protocol.

Front Oncol

April 2022

Department of Epidemiology and Public Health, and Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.

Breast cancer is now the commonest cancer in most sub-Saharan African countries. Few studies of the epidemiology and genomics of breast cancer and its molecular subtypes in these countries have been done. The African Female Breast Cancer Epidemiology (AFBRECANE) study, a part of the Human Heredity and Health in Africa (H3Africa) initiative, is designed to study the genomics and epidemiology of breast cancer and its molecular subtypes in Nigerian women.

View Article and Find Full Text PDF

There is limited capacity and infrastructure in sub-Saharan Africa to conduct clinical trials for the identification of efficient and effective new prevention, diagnostic and treatment modalities to address the disproportionate burden of disease. This paper reports on the process to establish locally driven infrastructure for multicentre research and trials in Nigeria known as the Nigeria Implementation Science Alliance Model Innovation and Research Centres (NISA-MIRCs). We used a participatory approach to establish a research network of 21 high-volume health facilities selected from all 6 geopolitical zones in Nigeria capable of conducting clinical trials, implementation research using effectiveness-implementation hybrid designs and health system research.

View Article and Find Full Text PDF

Purpose: Knowledge of the prevalence of HPV infection among adolescent and early adult girls is essential to determining the best age for the introduction of HPV vaccine, monitoring vaccine efficacy, and giving insight into determinants of persistent high-risk HPV infection, a necessary cause of cervical cancer. Yet, there have been limited studies of HPV infection among adolescent and early adult girls in low-and-middle-income countries.

Methods: In this cross-sectional study, we randomly selected 205 girls, aged 9-20 years, from 10 schools in central Nigeria.

View Article and Find Full Text PDF

Objectives: Literature has assessed skilled birth attendants (SBAs) utilisation, but little is known about what contributes to the changes in SBA use. Multivariate decomposition analysis was thus applied in this study to examine; levels, trends, inequalities and drivers of changes in SBA utilisation.

Design And Setting: A cross-sectional analysis of five-waves of NDHS-data (1990, 2003, 2008, 2013, and 2018), collected through similar multistage sampling across the 36 states and the federal-capital-territory of Nigeria.

View Article and Find Full Text PDF

Emerging infections and pandemics: The critical importance of global health equity action.

Mol Ther

May 2022

Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, 1044 W Walnut Street, R4-402D, Indianapolis, IN 46202, USA. Electronic address:

View Article and Find Full Text PDF

Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study.

Lancet Microbe

July 2021

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland (K Zürcher MSc, M L Reichmuth MSc, M Ballif PhD, V Skrivankova PhD, Prof L Fenner MD, Prof M Egger MD); Swiss Tropical and Public Health Institute, Basel, Switzerland (C Loiseau PhD, S Borrell PhD, M Reinhard, Prof S Gagneux PhD); University of Basel, Basel, Switzerland (C Loiseau, S Borrell, M Reinhard, Prof S Gagneux); Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland (R Hömke, P Sander MD, Prof E C Böttger MD); Swiss National Center for Mycobacteria, Zurich, Switzerland (R Hömke, P Sander, Prof E C Böttger); The HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre and Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (A Avihingsanon MD); Institute of Human Virology Nigeria, Abuja, Nigeria (Prof A G Abimiku PhD); Centre de Prise en Charge de Recherche et de Formation, Yopougon, Abidjan, Côte d'Ivoire (O Marcy MD); Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru (J Collantes MSc); Department of Medicine, Moi University School of Medicine, and Moi Teaching and Referral Hospital, Eldoret, Kenya (Prof E J Carter MD); Brown University School of Medicine, Providence, RI, USA (Prof E J Carter); Wellcome Centre for Infectious Diseases Research in Africa (Prof R J Wilkinson PhD, Prof H Cox PhD), Institute for Infectious Disease and Molecular Medicine (Prof H Cox), and Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences (Prof M Egger), University of Cape Town, Cape Town, South Africa; Department of Infectious Diseases, Imperial College London, London, UK (Prof R J Wilkinson); The Francis Crick Institute, London, UK (Prof R J Wilkinson); National TB Lab, Kinshasa, Democratic Republic of the Congo (Prof M Yotebieng MD); Albert Einstein College of Medicine, New York, NY, USA (Prof M Yotebieng); National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA (R Huebner PhD).

Background: Drug resistance threatens global tuberculosis control. We aimed to examine mortality in patients with tuberculosis from high-burden countries, according to concordance or discordance of results from drug susceptibility testing done locally and whole-genome sequencing (WGS).

Methods: In this multicentre cohort study, we collected pulmonary isolates and clinical data from individuals with tuberculosis from antiretroviral therapy programmes and tuberculosis clinics in Côte d'Ivoire, Democratic Republic of the Congo, Kenya, Nigeria, Peru, South Africa, and Thailand, stratified by HIV status and drug resistance.

View Article and Find Full Text PDF

Introduction: While antiretroviral therapy (ART) coverage for pregnant women has undergone steady scale-up, Nigeria's final mother- to-child transmission of HIV (MTCT) rate remains unacceptably high at 10%. This study aimed to determine final outcomes (MTCT rates) and their correlates among HIV-exposed infants (HEI) in nine states and the Federal Capital Territory, Nigeria.

Methods: This retrospective, cross-sectional study was conducted at 96 primary, secondary and tertiary health facilities supported by the Institute of Human Virology Nigeria.

View Article and Find Full Text PDF

Background: Understanding the correlates of disengagement from HIV care and treatment failure during second-line antiretroviral therapy (ART) could inform interventions to improve clinical outcomes among people living with HIV (PLHIV).

Methods: We conducted a retrospective cohort study of PLHIV aged >15 years who started second-line ART at a tertiary center in Nigeria between 2005 and 2017. Participants were considered to have disengaged from care if they had not returned within a year after each clinic visit.

View Article and Find Full Text PDF

Importance: Little is known about COVID-19 outcomes among children and adolescents in sub-Saharan Africa, where preexisting comorbidities are prevalent.

Objective: To assess the clinical outcomes and factors associated with outcomes among children and adolescents hospitalized with COVID-19 in 6 countries in sub-Saharan Africa.

Design, Setting, And Participants: This cohort study was a retrospective record review of data from 25 hospitals in the Democratic Republic of the Congo, Ghana, Kenya, Nigeria, South Africa, and Uganda from March 1 to December 31, 2020, and included 469 hospitalized patients aged 0 to 19 years with SARS-CoV-2 infection.

View Article and Find Full Text PDF

Background: Multiple anal human papillomavirus (HPVs) may increase the risk of anal cancer among men who have sex with men (MSM) living with human immunodeficiency virus (HIV). The Jaccard Similarity Index (JSI) was explored as a measure of multiple HPV persistence.

Methods: The TRUST/RV368 cohort enrolled MSM living with and without HIV in Abuja and Lagos, Nigeria.

View Article and Find Full Text PDF

Background: Deep sequencing could improve understanding of HIV treatment failure and viral population dynamics. However, this tool is often inaccessible in low- and middle-income countries.

Objectives: To determine the genetic patterns of resistance emerging in West African HIV-1 subtypes during first-line virological failure, and the implications for future antiretroviral options.

View Article and Find Full Text PDF

Background: Nigeria has a high burden of hepatitis B virus (HBV) infection, commonly acquired through vertical transmission. However, there is a lack of an efficient surveillance system for monitoring and understanding the epidemiology of HBV among pregnant women. Building on a previous review on the prevalence of HBV in Nigeria (2000-2013), we conducted a systematic review and meta-analysis of HBV prevalence among pregnant women in Nigeria.

View Article and Find Full Text PDF

Background: New medicines have become available for the treatment of drug-resistant tuberculosis (DR-TB) and are introduced in sub-Saharan Africa (SSA) by the national TB programs (NTPs) through special access schemes. Pharmacovigilance is typically the task of national medicines regulatory agencies (NMRAs), but the active drug safety monitoring and management (aDSM) recommended for the new TB medicines and regimens was introduced through the NTPs. We assessed the strengths and challenges of pharmacovigilance systems in Eswatini, Ethiopia, Nigeria and Tanzania, focusing on their capacity to monitor safety of medicines registered and not registered by the NMRAs for the treatment of DR-TB.

View Article and Find Full Text PDF

Sustainable and equitable partnerships and collaborations between the Global North and Global South (as well as within the Global South) have been aspirations (if seldom achieved) of the "global health" endeavor over the past couple of decades. The COVID-19 pandemic led to global lockdowns that disrupted international travel and severely challenged these partnerships, providing a critical space for self-reflection on global health as a discipline. One major global north-south partnership is that between the African Forum for Research and Education in Health (AFREhealth) and the Consortium of Universities for Global Health (CUGH).

View Article and Find Full Text PDF

Background: Mentor mothers provide psychosocial and other support to pregnant and post-partum women living with HIV (WLHIV), which has been shown to enhance maternal-infant outcomes in the prevention of mother-to-child transmission of HIV (PMTCT). Our objective was to assess the acceptability of mentor mothers as a PMTCT intervention, and to explore opinions on mentor mother program composition and delivery among stakeholders in North-Central Nigeria.

Methods: We conducted nine focus group discussions and 31 in-depth interviews with 118 participants, including WLHIV, pregnant women, male partners, health workers, traditional birth attendants, community leaders, PMTCT program implementers, and policymakers.

View Article and Find Full Text PDF

Introduction: Adolescents and young people comprise a growing proportion of new HIV infections globally, yet current approaches do not effectively engage this group, and adolescent HIV-related outcomes are the poorest among all age groups. Providing psychosocial interventions incorporating psychological, social, and/or behavioural approaches offer a potential pathway to improve engagement in care and health and behavioural outcomes among adolescents and young people living with HIV (AYPLHIV).

Methods: A systematic search of all peer-reviewed papers published between January 2000 and July 2020 was conducted through four electronic databases (Cochrane Library, PsycINFO, PubMed and Scopus).

View Article and Find Full Text PDF

Recent evidence suggests that, in some foci, elimination of onchocerciasis from Africa may be feasible with mass drug administration (MDA) of ivermectin. To achieve continental elimination of transmission, mapping surveys will need to be conducted across all implementation units (IUs) for which endemicity status is currently unknown. Using boosted regression tree models with optimised hyperparameter selection, we estimated environmental suitability for onchocerciasis at the 5 × 5-km resolution across Africa.

View Article and Find Full Text PDF

Background: Despite the development of a safe and efficacious hepatitis B vaccine in 1982, the hepatitis B virus (HBV) remains a public health burden in sub-Saharan Africa. Due to shared risk factors for virus acquisition, men who have sex with men (MSM) and transgender women (TGW) living with HIV are at increased risk of HBV. We estimated the prevalence of HBV and associated factors for MSM and TGW living with or without HIV in Nigeria.

View Article and Find Full Text PDF